Articles

Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA
Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA
CIBMTR, Minneapolis, MN, USA
Rush University Medical Center, Chicago, IL, USA
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
National Cancer Hospital, Tokyo, Japan
Emory University School of Medicine, Atlanta, GA, USA
University of Minnesota, Minneapolis, MN, USA
United Bristol Health Care Trust, UK
Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
Stanford University School of Medicine, CA, USA
H Lee Moffitt Cancer Center, Tampa, FL, USA
Karolinska Institute, Huddinge, Sweden
Indiana University School of Medicine, Indianapolis, IN, USA
US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA
University of Central Florida College of Medicine, Orlando, FL, USA
Columbia University Medical Center, New York, NY, USA
Katholieke Universiteit, Lueven, Belgium
Emory University School of Medicine, Atlanta, GA, USA
University of Minnesota, Minneapolis, MN, USA
University of Stony Brook, NY, USA
Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA
MD Anderson Cancer Research Center, Houston, TX, USA
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
H Lee Moffitt Cancer Center, Tampa, FL, USA
CIBMTR, Minneapolis, MN, USA;University of Minnesota, Minneapolis, MN, USA
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Vol. 103 No. 10 (2018): October, 2018 https://doi.org/10.3324/haematol.2017.182550